Health
Comparison of oral vs intravenous etoposide in the management of small‐cell lung cancer: A real‐world, population‐based study – MD Linx
MDLinx original journal summary on Lung Cancer, Pulmonology from The Clinical Respiratory Journal
For firstline treatment in smallcell lung cancer (SCLC), researchers assessed whether PO vs IV etoposide is useful in combination with a platinum agent (cisplatin/carboplatin) in this study including 2,066 patients with SCLC. Based on stage, patients were divided as limited disease and extensive disease. Route of etoposide administration, dose reductions and vital status was evaluated in chemotherapy naïve patients receiving one cycle of combination chemotherapy. Findings revealed similar overal…
-
General21 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General6 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General20 hours agoA culture of leniency. Exposing wrongdoing or protecting wrongdoers?
-
Noosa News21 hours agoWorker rushed to hospital after becoming trapped in machinery during horror workplace accident in Salisbury